Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 1/2019

01-01-2019 | Correspondence

Preventive Effects of Epinephrine for Critically Ill Patients? More Questions Waiting to Be Answered

Authors: Shanlan Shi, Yi Lin, Ru Ding, Yihong Chen, Feng Wu, Zhiqing He, Zonggui Wu, Chun Liang

Published in: Digestive Diseases and Sciences | Issue 1/2019

Login to get access

Excerpt

To the Editors, …
Literature
1.
Becq A, Urien S, Barret M, et al. Epinephrine dose has a preventive effect on the occurrence of stress ulcer-induced gastrointestinal bleeding in critically ill patients. Dig Dis Sci. 2018;63:2687–2694.CrossRef
2.
Levy B, Clere-Jehl R, Legras A, et al. Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2018;72:173–182.CrossRef
3.
Joannidis M, Druml W, Forni LG, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med. 2017;43:730–749.CrossRef
4.
Shiao CC, Wu PC, Huang TM, et al. Long-term remote organ consequences following acute kidney injury. Crit Care. 2015;19:438.CrossRef
5.
Perkins GD, Ji C, Deakin CD, et al. A randomized trial of epinephrine in out-of-hospital cardiac arrest. N Engl J Med. 2018;379:711–721.CrossRef
6.
7.
Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994;330:377–381.CrossRef
8.
Spirt MJ. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther. 2004;26:197–213.CrossRef
Metadata
Title
Preventive Effects of Epinephrine for Critically Ill Patients? More Questions Waiting to Be Answered
Authors
Shanlan Shi
Yi Lin
Ru Ding
Yihong Chen
Feng Wu
Zhiqing He
Zonggui Wu
Chun Liang
Publication date
01-01-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5386-8

Other articles of this Issue 1/2019

Digestive Diseases and Sciences 1/2019 Go to the issue

Original Article

Declining Rates of Referral for Irritable Bowel Syndrome Without Constipation at a Tertiary Care Center

Original Article

Clinical Significance of the Thioredoxin System and Thioredoxin-Domain-Containing Protein Family in Hepatocellular Carcinoma

Editorial

Medical Prophylaxis of Post-Surgical Crohn’s Disease Recurrence: Towards Timely Anti-TNF Therapy

Original Article

Active β-Catenin Signaling in the Small Intestine of Humans During Infancy

Original Article

Elevated Tryptase in EoE Is an Independent Phenomenon Associated with Extra-Esophageal Symptoms

Multicenter Seminars: IBD (MUSE: IBD)

Introduction to the IBD Case Conference Series
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits